Effect of everolimus-eluting stent versus sirolimus and paclitaxel eluting stent or balloon angioplasty alone in patients with sirolimus-eluting stent restenosis lesion and stent fracture

Trial Profile

Effect of everolimus-eluting stent versus sirolimus and paclitaxel eluting stent or balloon angioplasty alone in patients with sirolimus-eluting stent restenosis lesion and stent fracture

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 May 2015

At a glance

  • Drugs Everolimus (Primary) ; Paclitaxel; Sirolimus
  • Indications Restenosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top